13.75
+0.10
+(0.73%)
At close: 1:29:36 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
--
66,397.00
1,246.00
Cost of Revenue
--
--
--
913.00
1,043.00
Gross Profit
--
--
--
65,484.00
203.00
Operating Expense
169,556.00
169,556.00
90,176.00
80,785.00
98,761.00
Operating Income
-169,556.00
-169,556.00
-90,176.00
-15,301.00
-98,558.00
Net Non Operating Interest Income Expense
2,744.00
2,744.00
1,625.00
1,323.00
3,452.00
Pretax Income
-170,683.00
-170,683.00
-76,177.00
-15,297.00
-100,507.00
Tax Provision
--
--
--
--
1,351.00
Net Income Common Stockholders
-170,683.00
-170,683.00
-76,177.00
-15,297.00
-101,858.00
Diluted NI Available to Com Stockholders
-170,683.00
-170,683.00
-76,177.00
-15,297.00
-101,858.00
Basic EPS
-2.33
--
-1.13
-0.22
-1.45
Diluted EPS
-2.33
--
-1.13
-0.22
-1.45
Basic Average Shares
73,176.00
--
67,434.00
70,221.77
70,221.77
Diluted Average Shares
73,176.00
--
67,434.00
70,221.77
70,221.77
Total Expenses
169,556.00
169,556.00
90,176.00
81,698.00
99,804.00
Net Income from Continuing & Discontinued Operation
-170,683.00
-170,683.00
-76,177.00
-15,297.00
-101,858.00
Normalized Income
-170,683.00
-170,683.00
-76,177.00
-15,297.00
-101,858.00
Interest Income
2,831.00
2,831.00
1,673.00
1,409.00
3,472.00
Interest Expense
87.00
87.00
48.00
86.00
20.00
Net Interest Income
2,744.00
2,744.00
1,625.00
1,323.00
3,452.00
EBIT
-170,596.00
-170,596.00
-76,129.00
-15,211.00
-100,487.00
EBITDA
-160,857.00
-160,857.00
-65,777.00
-4,112.00
-88,815.00
Reconciled Cost of Revenue
--
--
--
913.00
1,043.00
Reconciled Depreciation
9,739.00
9,739.00
10,352.00
11,099.00
11,672.00
Net Income from Continuing Operation Net Minority Interest
-170,683.00
-170,683.00
-76,177.00
-15,297.00
-101,858.00
Normalized EBITDA
-160,857.00
-160,857.00
-65,777.00
-4,112.00
-88,815.00
Tax Rate for Calcs
--
--
--
--
0.00
12/31/2020 - 12/27/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6549.TWO TaiwanJ Pharmaceuticals Co., Ltd.
8.20
-0.12%
6580.TWO TaiRx, Inc.
26.10
+2.35%
4197.TWO Visgeneer Inc.
9.78
0.00%
6709.TWO Advagene Biopharma Co., Ltd.
20.25
+0.25%
4195.TWO Genomics BioSci & Tech. Co.,Ltd.
18.90
+2.16%
6652.TWO Eusol Biotech Co.,Ltd.
7.77
-0.38%
6634.TWO Sinew Pharma Inc.
49.45
-0.40%
4178.TWO StemCyte International, Ltd.
35.00
+1.16%
4194.TWO Holy Stone Healthcare Co., Ltd.
11.40
-0.44%
4170.TWO VBI
14.10
+0.71%